Form 4 for AXGN Axogen, Inc.
Accepted 2021-11-29 00:00:00 ET · period of report 2021-11-24 · accession 0000805928-21-000171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-29 | 2021-11-24 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $8.95 | +52.4K | 921.1K | +6% | +$468.8K |
| D | 2021-11-29 | 2021-11-24 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $8.95 | -52.4K | 157.1K | -25% | -$468.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | M | A | 52,375 | $8.95 | 921,147 | D | — | — | (F1) The Reporting Person has elected to exercise and hold the shares at this time. |
| 2 | Derivative | Employee Stock Option (right to purchase) | 2021-11-24 | M | D | 52,375 | $8.95 | 157,125 | D | $8.95 · 2020-12-29 to 2026-12-29 | 52,375 Common Stock | (F1) The Reporting Person has elected to exercise and hold the shares at this time. (F2) All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |